Document 0446
 DOCN  M9480446
 TI    Use of synthetic peptides in primates to induce high-titered
       neutralizing antibodies and MHC class I-restricted cytotoxic T cells
       against acquired immunodeficiency syndrome retroviruses: an HLA-based
       vaccine strategy.
 DT    9410
 AU    Haynes BF; Yasutomi Y; Torres JV; Gardner MB; Langlios AJ; Bolognesi DP;
       Matthews TJ; Scearce RM; Jones DM; Moody MA; et al; Department of
       Medicine, Duke University Arthritis Center, Durham,; NC.
 SO    Trans Assoc Am Physicians. 1993;106:33-41. Unique Identifier : AIDSLINE
       MED/94310728
 DE    Amino Acid Sequence  Animal  AIDS Vaccines/IMMUNOLOGY/ISOLATION &
       PURIF/*PHARMACOLOGY  Histocompatibility Antigens Class I  Human  HIV
       Antibodies/*BIOSYNTHESIS  HIV Envelope Protein gp120/GENETICS/IMMUNOLOGY
       HIV Infections/PREVENTION & CONTROL  HLA Antigens  Macaca mulatta
       Molecular Sequence Data  Neutralization Tests  Peptide
       Fragments/GENETICS/IMMUNOLOGY  Peptides/CHEMICAL
       SYNTHESIS/GENETICS/*IMMUNOLOGY  Support, Non-U.S. Gov't  Support, U.S.
       Gov't, P.H.S.  SIV/GENETICS/IMMUNOLOGY  T-Lymphocytes,
       Cytotoxic/*IMMUNOLOGY  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).